Image

North America Next Generation Sequencing (NGS) Market – Industry Trends and Forecast to 2030

Healthcare

Image

North America Next Generation Sequencing (NGS) Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Mar 2024
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Next Generation Sequencing (NGS) Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3,489.40 USD Million
Diagram Market Size (Forecast Year) USD 15,615.61 USD Million
Diagram CAGR %

Major Markets Players

  • Agilent Technologies
  • ThermoFisher Scientific
  • QIAGEN
  • Illumina
  • Bio-Rad Laboratories

North America Next Generation Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research, Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes, Hospital & Clinics) – Industry Trends and Forecast to 2030.

North America Next Generation Sequencing (NGS) Market

North America Next Generation Sequencing (NGS) Market Analysis and Size

High-throughput sequencing, most widely regarded as the "next-generation" sequencing (NGS), is now integrated into routine clinical practice due to the numerous technical and functional developments, while early protocols relied on samples harvested outside of typical workflows in clinical pathology, standard formalin-fixed, paraffin-embedded specimens which can be used more regularly as starting material for NGS.

Data Bridge Market Research analyzes that the North America next generation sequencing (NGS) market, which was USD 3489.40 million in 2022, will reach USD 15615.61 million by 2030 and is expected to undergo a CAGR of 17.4% during the forecast period. The “consumables” segment dominates the product type segment of the market due to increasing incidence of neurological disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research, Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes, Hospital & Clinics)

Countries Covered

U.S., Canada, Mexico

Market Players Covered

Agilent Technologies, Inc. (U.S.), ThermoFisher Scientific, Inc. (U.S.), QIAGEN (Netherlands), llumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BGI (A subsidiary of BGI Group) (China), Oxford Nanopore Technologies plc (U.K.), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), 10x Genomics, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Genewiz (U.S.), Partek Incorporated (U.S.), Becton, Dickinson and Company (BD) (U.S.), Genomic Health, Inc. (U.S.), Guardant Health, Inc. (U.S.), Personalis, Inc. (U.S.)

Market Opportunities

  • Population genomics and precision medicine
  • Infectious disease genomics
  • Emerging markets

Market Definition

Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to a set of advanced techniques used to determine the nucleotide sequence of DNA (deoxyribonucleic acid) or RNA (ribonucleic acid) molecules. Unlike traditional Sanger sequencing methods, which were time-consuming and limited in scalability, NGS allows for the rapid and parallel sequencing of millions of DNA fragments.

North America Next Generation Sequencing (NGS) Market Dynamics

Drivers

  • Advancements in Genomic Research

The continuous advancements in genomic research and technology have propelled the demand for NGS. Researchers use NGS techniques to study complex genetic variations, enabling discoveries in personalized medicine, rare diseases, and cancer genomics.

  • Falling Sequencing Costs

The cost of sequencing has significantly decreased over the years, making NGS more accessible to researchers and healthcare providers. This reduction in costs encourages widespread adoption, especially in clinical settings.

  • Rising Applications in Clinical Diagnostics

NGS is increasingly utilized for clinical diagnostics, including cancer screening, prenatal testing, and rare disease identification. The expanding scope of applications in healthcare drives market growth.

Opportunities

  • Oncology Diagnostics

NGS plays a crucial role in cancer genomics, aiding in targeted therapies, identifying biomarkers, and predicting treatment responses. The expanding field of oncology diagnostics offers significant growth opportunities.

  • Population Genomics and Precision Medicine

Large-scale population genomics projects enable researchers to understand genetic variations in diverse populations. NGS contributes to precision medicine initiatives by tailoring treatments based on individual genetic profiles.

Restraints/ Challenges

  • Data Management and Analysis

NGS generates massive amounts of data, requiring robust computational resources and bioinformatics expertise for efficient data management, analysis, and interpretation. Handling and storing large datasets present challenges.  

  • Regulatory Challenges

NGS technologies are subject to stringent regulations, especially in clinical applications. Compliance with regulatory standards, including data privacy laws, can be complex and time-consuming.

This next generation sequencing (NGS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next generation sequencing (NGS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In October 2021, ThermoFisher Scientific Inc. announced that it has launched Applied Biosystem QuantSudio Absolute Q-Digital PCR System, which is a designed to provide highly accurate results in genetic analysis. The digital PCR is already in use for monitoring cancer driven mutations in liquid biopsy. This has helped he company to increase its product portfolio

North America Next Generation Sequencing (NGS) Market Scope

The next-generation sequencing (NGS) market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Instrument
  •  Consumables
  •  Services

Application

  • Diagnostic
  • Drug Discovery
  • Biomarker Discovery
  • Precision Medicine
  • Agriculture and Animal Research

End User

  • Hospitals & Clinics
  • Research Centers and Academic & Government Institutes
  • Pharmaceutical & Biotechnology Companies

North America Next Generation Sequencing (NGS) Market Region Analysis/Insights

The next generation sequencing (NGS) market is analyzed and market size insights and trends are provided by country, product, application, and end user as referenced above.

The countries covered in the market report are U.S., Canada, and Mexico.

The U.S. is expected to dominate and be the fastest-growing country in the market due to rising advancements in research activities. Also, due to higher investment and funding processes between the public-private partnerships.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, and Porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and the challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the region data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The next generation sequencing (NGS) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for next generation sequencing (NGS) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on next generation sequencing (NGS) market. The data is available for historic period 2010-2020.

Competitive Landscape and North America Next Generation Sequencing (NGS) Market Share Analysis

The next generation sequencing (NGS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to next generation sequencing (NGS) market research.

Some of the major players operating in the next generation sequencing (NGS) market are:

  • Agilent Technologies, Inc. (U.S.)
  • ThermoFisher Scientific, Inc. (U.S.)
  • QIAGEN (Netherlands)
  • Illumina, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • BGI (A subsidiary of BGI Group) (China)
  • Oxford Nanopore Technologies plc (United Kingdom)
  • Illumina, Inc. (U.S.)
  • Pacific Biosciences of California, Inc. (U.S.)
  • 10x Genomics, Inc. (U.S.)
  • PerkinElmer, Inc. (U.S.)
  • Genewiz (U.S.)
  • Partek Incorporated (U.S.)
  • Becton, Dickinson and Company (BD) (U.S.)
  • Genomic Health, Inc. (U.S.)
  • Guardant Health, Inc. (U.S.)
  • Personalis, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The next generation sequencing (NGS) market size will be worth USD 15615.61 million by 2030.
The growth rate of the next generation sequencing (NGS) market is 17.4%.
Product, application, and end user are the factors on which the next generation sequencing (NGS) market research is based.
Major companies in the next generation sequencing (NGS) market are Agilent Technologies, Inc. (U.S.), ThermoFisher Scientific, Inc. (U.S.), QIAGEN (Netherlands), llumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BGI (A subsidiary of BGI Group) (China), Oxford Nanopore Technologies plc (U.K.), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), 10x Genomics, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Genewiz (U.S.), Partek Incorporated (U.S.), Becton, Dickinson and Company (BD) (U.S.), Genomic Health, Inc. (U.S.), Guardant Health, Inc. (U.S.), Personalis, Inc. (U.S.).
Advancements in genomic research, falling sequencing costs & rising applications in clinical diagnostics are the growth drivers of the next generation sequencing (NGS) market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials